Recommended articles An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism Ren Q, Chen S, Chen X, Niu S, Yue L, Pan X, Li Z, Chen X Drug Design, Development and Therapy 2022, 16:3723-3735 Published Date: 25 October 2022 Field-Based Estimates of Muscle Quality Index Determine Timed-Up-and-Go Test Performance in Obese Older Women Neto IVDS, Diniz JDS, Alves VP, Ventura Oliveira AR, Barbosa MPDS, da Silva Prado CR, Alencar JA, Vilaa e Silva KHC, Silva CR, Lissemerki Ferreira GM, Garcia D, Grisa RA, Prestes J, Rodrigues Melo GL, Burmann LL, Gomes Giuliani FN, Beal FLR, Severiano AP, Nascimento DDC Clinical Interventions in Aging 2023, 18:293-303 Published Date: 22 February 2023 Relationship Between Physical Exercise and Cognitive Impairment Among Older Adults with Type 2 Diabetes: Chain Mediating Roles of Sleep Quality and Depression Zhang H, Zhang Y, Sheng S, Xing Y, Mou Z, Zhang Y, Shi Z, Yu Z, Gao Q, Cai W, Jing Q Psychology Research and Behavior Management 2023, 16:817-828 Published Date: 17 March 2023 Management of Glucose-Lowering Therapy in Older Adults with Type 2 Diabetes: Challenges and Opportunities Doucet J, Gourdy P, Meyer L, Benabdelmoumene N, Bourdel-Marchasson I Clinical Interventions in Aging 2023, 18:1687-1703 Published Date: 9 October 2023 Imaging of Sarcopenia in Type 2 Diabetes Mellitus Wang D, Zhang G, Yu Y, Zhang Z Clinical Interventions in Aging 2024, 19:141-151 Published Date: 26 January 2024
Semaglutide remains in the body for several weeks after the last dose, and animal studies showed potential fetal risks
The biological mechanisms, although understood to involve antioxidant, anti-inflammatory, and gene upregulation pathways, are still under active investigation
PMID: 29974401
The troubleshooting mindset you used during treatment applies here too
For some, semaglutide may work incredibly well
